Abstract:Introduction Cardiac amyloidosis is a rare and progressive form of restrictive cardiomyopathy which is associated with a poor prognosis. Two types of amyloid proteins commonly infiltrate the heart: i) immunoglobulin light-chain (AL or primary systemic) amyloid and ii) transthyretin (ATTR) amyloid. ATTR is the predominant hereditary form of cardiac amyloidosis, characterized by abnormal deposition of insoluble misfolded transthyretin protein fibrils in the myocardium resulting in organ dysfunction. The actual prevalence of ATTR amyloidosis is unknown, although recent data suggest that it is overlooked as a cause of common cardiovascular disease (CVD) especially in older people, including patients with heart failure with preserved ejection fraction (HFpEF), low-flow aortic stenosis, and atrial fibrillation. Objectives to identify patients with high-risk features for cardiac amyloidosis and assess for screening of transthyretin amyloidosis cardiomyopathy (ATTR-CM) among these patients at a safety net hospital Atlanta, GA. Methods We performed a systematic chart review of patients who had an echocardiogram between January 2018 and December 2021 at our institution. Adults aged 18 years or older with a diagnosis of cardiomyopathy or heart failure, and a left ventricular posterior wall (LVPWd) or interventricular septal wall (IVSd) thickness in diastole greater than or equal to 1.4 cm on echocardiogram were included. Patients with diagnosed AL amyloidosis and those with aortic stenosis were excluded. Variables collected included LVPWd, IVSd, gender, race, data on diagnostic modalities such as cardiac MRI (CMR), technetium pyrophosphate 99mTc scintigraphy (PYP scan), endomyocardial biopsy (EMB), and a diagnosis of cardiac amyloidosis. Results A total of 594 patients met the inclusion criteria. Of those, 215 (36.1%) were females, and 379 (63.9%) were males. Race analysis showed 91.6% were African American, 5% White, 2.1% Other and 1.1% Asian. Of the 594 included patients, only 16 (2.7%) had CMR, 68 (11.4%) had PYP scan, and 2 (0.33%) had EMB. 10 patients (1.7%) were positive for ATTR (8 of these diagnosed by PYP scan, and 2 by EMB). Discussion Less than 15% of the patients with high risk features for ATTR-CM at our institution had additional screening for this disease. These results demonstrate underutilization of imaging modalities, specifically PYP scan and CMR for the diagnosis of cardiac amyloidosis for at-risk patients at our institution. ATTR-CM is a re-emerging clinical entity that will require a high index of clinical suspicion in routine cardiac care for early diagnosis. Another project is underway focused on assessing healthcare provider and patient gaps in knowledge on the clinical features of ATTR-CM, as well as diagnosis and management of patients with cardiac amyloidosis.

Assessing Screening For Transthyretin Cardiac Amyloidosis Among Patients At A Safety Net Hospital In Metro Atlanta